Ophthalmic Sciences For Profit
Op-Sci is developing a first in market AI technology to help 150M patients worldwide from going blind in a $7B market. The IOPerfect visor bridges the competition’s unmet need for user-friendly, accurate and affordable eye pressure tracking, a key biomarker for glaucoma management. Our team has over seventy years of combined experience backed by the world’s top glaucoma surgeons. We were already awarded $1.4M USD to reach proof of concept and are now seeking additional financing to get us to market readiness in 2023.
Founded Date:
2019-09-01
Headquarters:
Tel Aviv, Tel Aviv, Israel
Technology:
Biomarkers of Aging
Industry:
AI for Longevity